Pfizer sells its Adams confectionery business to Cadbury Schweppes

On December 16, 2002, Pfizer Inc. (?Pfizer?) agreed to sell its Adams confectionery business to Cadbury Schweppes plc (?Cadbury?). Under the terms of the stock and asset purchase agreement between Pfizer and Cadbury, Cadbury and certain of its affiliates purchased the stock or assets of certain of Pfizer?s affiliates. The sale was closed on March 30, 2003. In Argentina, Pfizer?s 100% beneficial ownership in subsidiary Adams S.A. was transferred to Cadbury.

Pfizer, Inc. was assisted in New York by Cadwalader, Wickersham & Taft LLP by partner Dennis Block and associate Michael Arouh, and concerning Mercosur matters by associate Maria Guerra and in Argentina by Marval, O´Farrell & Mairal with a team leaded by partners Héctor A. Mairal and Alejandro D. Fiuza and which included associate Claudia Paluszkiewicz. Cadbury was assisted in New York by Sherman Stearling partner Creighton Condon, counsel Kenneth Gerasimovich and associate Andrew Noreuil; and in Argentina by Allende & Brea